BRD2 and cardiovascular disorder: Recently, the chronically elevated levels of follicle stimulating hormone (FSH) present during the menopausal transition have been identified as playing a role in postmenopausal osteoporosis and cardiovascular disease [9], rather than the decline in the protective effect of estrogen during and/or after the menopause.